CENTELLASE 30CPR 30MG

CENTELLASE COMPRESITION

active ingredients

1 tablet contains: total triterpenic fraction of the Asian centella (Asiaticoside 40% – Asian acid + 60% acid) 30 mg. For the complete list of excipients, see paragraph 6.1.

Excellent

Dihydrate dibasic phosphate calcium, sodium docusate, povidone, sodium croscarmellosa, sodium carmellosa, magnesium stearate.

Therapeutic indications

Symptoms attributable to venous failure; states of capillary fragility.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients listed in paragraph 6.1.

Population

Population From 1 to 2 tablets per day, preferably at the time of meals. The medicinal product must be used only for a short period of treatment. Method of administration: oral use.

Conservation

This medicine does not require any special condition of conservation.

Warnings

No special precaution for the use of the product.

Interactions

There are no known interactions with other drugs.

Effects

Cases of itching and photosensitivity reactions with appearance of redness and rashes after oral administration of the drug were reported. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at: http://www.agenziafarmaco.gov.it/it/responsabili.

Overdosing

No overdose cases have been reported.

Animal studies have not shown reproductive toxicity. There is no adequate data from the use of the drug in pregnant women or during breastfeeding. Centellase should not be used during pregnancy and nursing.

Source: Farmadati